JPRN-UMIN000015686
Completed
未知
A clinical multicenter study on efficacy and safety of C1-inhibitor concentrate for clinical amniotic fluid embolism - A clinical multicenter study on efficacy and safety of C1-inhibitor concentrate for clinical amniotic fluid embolism
Obstetrics and Gynecology, Hamamatsu University School of Medicine.0 sites30 target enrollmentNovember 13, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Obstetrics and Gynecology, Hamamatsu University School of Medicine.
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with anaphylactic reaction to C1\-inhibitor concentrate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A Study to Evaluate Efficacy of DDX-01 which Supports Screening for Diabetic Retinopathy and Diabetic Macular EdemaDiabetisJPRN-jRCT2032220358Tomita Koji275
Active, not recruiting
Phase 1
A multicentre study to assess the safety and efficacy of sodium hyaluronate (Hyalgan-F) produced by fermentation in knee psteoarthritis.Knee oasteoarthritisEUCTR2005-002735-27-LVFidia Farmaceutici SpA120
Completed
Phase 2
A multicentre study to assess safety and efficacy of COMP360 in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)treatment resistant depression10027946NL-OMON55052COMPASS Pathfinder Ltd3
Active, not recruiting
Phase 1
ong Term Follow up study for subjects that participated in COMP001 and COMP003 trialTreatment-Resistant Depression (P-TRD)MedDRA version: 21.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873MedDRA version: 21.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2020-001348-25-CZCOMPASS Pathfinder, Ltd150
Active, not recruiting
Phase 1
ong Term Follow up study for subjects that participated in COMP001 and COMP003 trialEUCTR2020-001348-25-PTCOMPASS Pathways, Ltd150